» Articles » PMID: 29262657

Hsa-miR-29c-3p Regulates Biological Function of Colorectal Cancer by Targeting SPARC

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Dec 22
PMID 29262657
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is the most common type of behavioral cancers, miRNAs play a critical role in cancer development and progression. In the present study, we downloaded the original data from Gene Expression Omnibus (GEO) and conduct data analysis. has-mir-29c-3p mimic, inhibitor, negative control or si-SPARC (secreted protein acidic, rich in cysteine) were transfected into HCT116 cells, respectively. Quantitative real time PCR (qRT-PCR) was used to measure has-mir-29c-3p and SPARC mRNA expressions, western blot was used to detect ACAA1 (acetyl-CoA acyltransferase 1), ACOX1 (acyl-CoA oxidase 1), COL1A1(collagen, type I, alpha-1), COL1A2 (collagen, type I, alpha-2), COL4A1 (collagen, type IV, alpha-1), COL5A2 (collagen, type V, alpha-2), COL12A1 (collagen, type XII, alpha-1), CPT2 (carnitine palmitoyltransferase 2), ETHE1 (persulfide dioxygenase), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2), SPARC, SQRDL (sulfide quinone oxidoreductase), and TST (thiosulfate sulfurtransferase) protein expression. CCK-8 and wound healing assay were employed to verify cell proliferation and migration. The luciferase reporter assay data made sure the target correlation of has-mir-29c-3p and SPARC. Firstly, we found that the expression of has-mir-29c-3p was lower in CRC tissues than in their paired corresponding non-cancerous tissues and there was significant inversed correlation between has-mir-29c-3p and SPARC. Overexpression of has-mir-29c-3p reduced cell proliferation and migration. SPARC was identified as a direct target of has-mir-29c-3p, whose silencing reduced cell proliferation and migration. These data showed that has-mir-29c-3p regulates CRC cell functions through regulating SPARC expression. Taken together, has-mir-29c-3p may function as an oncogenic miRNA targeting SPARC, targeted modulation of has-mir-29c-3p expression may became a potential strategy for the treatment.

Citing Articles

Identification and validation of key genes in gastric cancer: insights from analysis, clinical samples, and functional assays.

Pei X, Luo Y, Zeng H, Jamil M, Liu X, Jiang B Aging (Albany NY). 2024; 16(12):10615-10635.

PMID: 38913913 PMC: 11236316. DOI: 10.18632/aging.205965.


GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs.

Ji Q, Zhu H, Qin Y, Zhang R, Wang L, Zhang E Front Pharmacol. 2024; 15:1329636.

PMID: 38323081 PMC: 10844528. DOI: 10.3389/fphar.2024.1329636.


Analysis of miRNAs in Caused by Mutations in and : Insights into Molecular Mechanisms and Potential Therapeutic Targets.

Botor M, Augusciak-Duma A, Lesiak M, Sieron L, Dziedzic-Kowalska A, Witecka J Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895885 PMC: 10609877. DOI: 10.3390/ph16101414.


Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.

Yadav S, Jauhari A, Singh N, Pandey A, Sarkar S, Pandey S Cell Mol Neurobiol. 2023; 43(7):3527-3553.

PMID: 37219663 PMC: 11410010. DOI: 10.1007/s10571-023-01362-4.


Identification and validation of a novel stress granules-related prognostic model in colorectal cancer.

Liu Z, Zhao E, Li H, Lin D, Huang C, Zhou Y Front Genet. 2023; 14:1105368.

PMID: 37205121 PMC: 10187888. DOI: 10.3389/fgene.2023.1105368.


References
1.
Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

2.
Kuo T, Hsi E, Yang I, Tsai P, Wang J, Juo S . Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. PLoS One. 2012; 7(2):e31587. PMC: 3278467. DOI: 10.1371/journal.pone.0031587. View

3.
Koukourakis M, Giatromanolaki A, Brekken R, Sivridis E, Gatter K, Harris A . Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res. 2003; 63(17):5376-80. View

4.
Zhang H, Jiang L, Sun D, Li J, Tang J . MiR-139-5p: promising biomarker for cancer. Tumour Biol. 2015; 36(3):1355-65. DOI: 10.1007/s13277-015-3199-3. View

5.
Zhao J, Lin J, Lwin T, Yang H, Guo J, Kong W . microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood. 2010; 115(13):2630-9. PMC: 2852365. DOI: 10.1182/blood-2009-09-243147. View